Fiche publication
Date publication
mars 2013
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ADOTEVI Olivier
,
Dr GODET Yann
Tous les auteurs :
Dosset M, Vauchy C, Beziaud L, Adotevi O, Godet Y
Lien Pubmed
Résumé
Accumulating evidence demonstrates the importance of CD4+ T cells in antitumor immune responses. Identifying promiscuous MHC class II-binding peptides derived from relevant tumor-associated antigens that specifically target CD4+ helper T cells in vivo represent a powerful approach to fully exploit these cells for anticancer immunotherapy.
Référence
Oncoimmunology. 2013 Mar 1;2(3):e23430.
